1. Home
  2. RYTM vs XRAY Comparison

RYTM vs XRAY Comparison

Compare RYTM & XRAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • XRAY
  • Stock Information
  • Founded
  • RYTM 2008
  • XRAY 1899
  • Country
  • RYTM United States
  • XRAY United States
  • Employees
  • RYTM N/A
  • XRAY N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • XRAY Medical/Dental Instruments
  • Sector
  • RYTM Health Care
  • XRAY Health Care
  • Exchange
  • RYTM Nasdaq
  • XRAY Nasdaq
  • Market Cap
  • RYTM 3.8B
  • XRAY 3.1B
  • IPO Year
  • RYTM 2017
  • XRAY 1987
  • Fundamental
  • Price
  • RYTM $61.74
  • XRAY $12.83
  • Analyst Decision
  • RYTM Strong Buy
  • XRAY Hold
  • Analyst Count
  • RYTM 12
  • XRAY 13
  • Target Price
  • RYTM $74.92
  • XRAY $23.36
  • AVG Volume (30 Days)
  • RYTM 940.6K
  • XRAY 3.7M
  • Earning Date
  • RYTM 05-06-2025
  • XRAY 05-08-2025
  • Dividend Yield
  • RYTM N/A
  • XRAY 4.98%
  • EPS Growth
  • RYTM N/A
  • XRAY N/A
  • EPS
  • RYTM N/A
  • XRAY N/A
  • Revenue
  • RYTM $130,126,000.00
  • XRAY $3,793,000,000.00
  • Revenue This Year
  • RYTM $43.84
  • XRAY N/A
  • Revenue Next Year
  • RYTM $65.62
  • XRAY $2.66
  • P/E Ratio
  • RYTM N/A
  • XRAY N/A
  • Revenue Growth
  • RYTM 68.06
  • XRAY N/A
  • 52 Week Low
  • RYTM $35.17
  • XRAY $12.16
  • 52 Week High
  • RYTM $68.58
  • XRAY $31.13
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 61.94
  • XRAY 34.37
  • Support Level
  • RYTM $59.54
  • XRAY $12.34
  • Resistance Level
  • RYTM $62.83
  • XRAY $13.14
  • Average True Range (ATR)
  • RYTM 4.27
  • XRAY 0.79
  • MACD
  • RYTM 1.00
  • XRAY -0.02
  • Stochastic Oscillator
  • RYTM 92.04
  • XRAY 22.79

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Share on Social Networks: